EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Multidrug-Resistant Tuberculosis in Rural Eastern Cape, South Africa: Clinical, Bacteriological, and Programmatic Predictors of Poor Treatment Outcomes

Mbulelo Cebisa, Ntandazo Dlatu, Mojisola Clara Hosu iD, Teke Apalata iD, Lindiwe Modest Faye iD

Microorganisms · 18.03.2026 · 14 (3) · 690

DOI: 10.3390/microorganisms14030690 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microorganisms, online erschienen am 18.03.2026. Verfasst von Mbulelo Cebisa und 4 weiteren Autor:innen. Beteiligte Einrichtung: TB and Associated Research and Innovation Platform (TARIP), WSU-TB Research Group, School of Pathology, Faculty of Medicine and Health Sciences, Walt…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Laboratory Medicine and Pathology, Faculty of Medicine and Health Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Drug-resistant tuberculosis (DR-TB), particularly multidrug-resistant TB (MDR-TB), remains a significant public health challenge in rural South Africa, where diagnostic and treatment infrastructure is limited. This study aimed to assess resistance patterns, bacillary load, treatment outcomes, and predictors of MDR-TB in the O.R. Tambo District of the Eastern Cape Province. Although isoniazid monoresistant TB (Hr-TB) was identified, its analysis was descriptive due to the limited sample size. A retrospective cohort analysis was conducted on bacteriologically confirmed TB cases (n = 477) diagnosed between 2020 and 2022. The data collected included demographic and clinical variables, smear and culture results, resistance patterns, and treatment outcomes. Drug resistance was categorized as MDR-TB, Hr-TB, or fully susceptible. Outcomes were classified as favorable, unfavorable, lost to follow-up, or ongoing. Logistic regression identified predictors of MDR-TB. DR-TB prevalence was 11.3% (n = 54), with MDR-TB accounting for 10.7% (n = 51) and Hr-TB for 0.6% (n = 3). Prior TB treatment was significantly associated with MDR-TB (adjusted odds ratio [aOR] 4.45, 95% CI: 1.89–10.48). Smear positivity was associated with MDR-TB in univariate analysis (OR 5.0), although its effect diminished in multivariable analysis (aOR 0.40, 95% CI: 0.12–1.36), suggesting confounding by bacillary load. Culture positivity was a strong independent predictor (aOR 27.71, 95% CI: 8.84–86.85), indicating a higher mycobacterial burden among MDR-TB cases. MDR-TB patients had significantly poorer treatment outcomes, with a high rate of unfavorable outcomes and loss to follow-up. MDR-TB dominates the resistance landscape in this rural district, primarily driven by prior treatment and high bacillary loads. The study highlights the need for targeted interventions, including enhanced diagnostic capacity, improved clinical governance, and community-based support systems, to optimize the detection and management of MDR-TB.

Schlagwörter

Stichwörter der Autor:innen

HIV coinfectionbacillary loadclinical governanceculture positivitydrug-resistance predictorsmultidrug-resistant tuberculosisretreatment tuberculosisrural health systemstreatment failure

Autor:innen und Institutionen

  • TB and Associated Research and Innovation Platform (TARIP), WSU-TB Research Group, School of Pathology, Faculty of Medicine and Health Sciences, Walter Sisulu University, Mthatha 5099, South Africa.
  • School of Public Health, Faculty of Medicine and Health Sciences, Walter Sisulu University, Mthatha 5099, South Africa.

ORCID-Profile: Mojisola Clara Hosu, Teke Apalata, Lindiwe Modest Faye

Förderung

  • Department of Laboratory Medicine and Pathology, Faculty of Medicine and Health Sciences

Zitieren

APA

Cebisa, M., Dlatu, N., Hosu, M. C., Apalata, T., & Faye, L. M. (2026). Multidrug-Resistant Tuberculosis in Rural Eastern Cape, South Africa: Clinical, Bacteriological, and Programmatic Predictors of Poor Treatment Outcomes. Microorganisms, 14(3), 690. https://doi.org/10.3390/microorganisms14030690

Vancouver

Cebisa M, Dlatu N, Hosu MC, Apalata T, Faye LM. Multidrug-Resistant Tuberculosis in Rural Eastern Cape, South Africa: Clinical, Bacteriological, and Programmatic Predictors of Poor Treatment Outcomes. Microorganisms. 2026;14(3):690. doi:10.3390/microorganisms14030690

BibTeX
@article{Cebisa2026,
  author = {Cebisa, Mbulelo and Dlatu, Ntandazo and Hosu, Mojisola Clara and Apalata, Teke and Faye, Lindiwe Modest},
  title = {Multidrug-Resistant Tuberculosis in Rural Eastern Cape, South Africa: Clinical, Bacteriological, and Programmatic Predictors of Poor Treatment Outcomes},
  journal = {Microorganisms},
  year = {2026},
  volume = {14},
  number = {3},
  pages = {690},
  doi = {10.3390/microorganisms14030690}
}
Kostenlos starten →